Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neuroblastoma 4Central Nervous System Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Multiple Myeloma 2Lung Neoplasms 2Leukemia 2Hodgkin Disease 2Brain Neoplasms 2Teratoma 1Seminoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Germ Cell Cancer 1Nonseminomatous germ cell tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Unknown Primary 1Neoplasms 1Nasopharyngeal Neoplasms 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1

Interventions

Vincristine 5Ifosfamide 5Etoposide 5Radiotherapy 4Doxorubicin 4Cyclophosphamide 4Dactinomycin 3Neoadjuvant Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2etoposide phosphate 1Topotecan 1Temozolomide 1Mesna 1Melphalan 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1FANG vaccine 1Epirubicin 1Dexrazoxane 1Cyproheptadine 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neuroectodermal Tumors, Primitive, Peripheral × etoposide phosphate × Clear all
NCT00006734 2023-08-03

Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor

Children's Oncology Group

Phase 3 Completed
587 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡